Prenatal BPA exposure tied to autism risk in boys

FHS
August 12, 2024
12:46 am

Study reveals that prenatal exposure to BPA disrupts aromatase activity in male brains, potentially leading to autism-like symptoms. Treatment with 10-HDA shows promise in reversing these effects.

FDA Rejects NK1R Antagonist for Gastroparesis

The FDA declined to approve tradipitant for adults with symptoms of gastroparesis, or delayed gastric emptying, drugmaker Vanda Pharmaceuticals announced on Thursday. Support for the

September 20, 2024

Study finds people with cognitive disabilities are less satisfied with health care

People with cognitive disabilities – like autism, attention deficit and memory loss – are less satisfied with their health care than those in the general

December 13, 2023

Shrinkage in the brain’s hippocampus area associated with cognitive decline

With the rise of new drugs that can target the amyloid-beta plaques in the brain that are an early sign of Alzheimer’s disease, new ways

November 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.